{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:25:48Z","timestamp":1778869548688,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019601","name":"Biomolecular Interaction Centre, University of Canterbury","doi-asserted-by":"publisher","award":["PR40154\/BTIS\/137\/34\/2021"],"award-info":[{"award-number":["PR40154\/BTIS\/137\/34\/2021"]}],"id":[{"id":"10.13039\/100019601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016148","name":"Department of Pharmaceutical Chemistry, University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jmgm.2025.109049","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:52:27Z","timestamp":1744372347000},"page":"109049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Designing novel potent oxindole derivatives as VEGFR2 inhibitors for cancer therapy: Computational insights from molecular docking, drug-likeness, DFT, and structural dynamics studies"],"prefix":"10.1016","volume":"138","author":[{"given":"Sowmiya","family":"Perinbaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manikandan","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyakanthan","family":"Jeyaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konda Reddy","family":"Girija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109049_bib1","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10528-023-10544-0","article-title":"Potential signature therapeutic biomarkers TOP2A, MAD2L1, and CDK1 in colorectal cancer: a systems biomedicine-based approach","volume":"62","author":"Priyamvada","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.jmgm.2025.109049_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.jmgm.2025.109049_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12032-023-02044-3","article-title":"Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review","volume":"40","author":"Anbarasu","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jmgm.2025.109049_bib4","volume":"vol. 9","author":"Debela","year":"2021"},{"key":"10.1016\/j.jmgm.2025.109049_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3556","article-title":"FN1 and cancer\u2010associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma","volume":"25","author":"Ashok","year":"2023","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jmgm.2025.109049_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112633","article-title":"Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2","volume":"406","author":"Huang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jmgm.2025.109049_bib7","first-page":"50","article-title":"Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions","volume":"22","author":"Shah","year":"2021","journal-title":"CDM"},{"key":"10.1016\/j.jmgm.2025.109049_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10637-019-00777-5","article-title":"Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a","volume":"38","author":"Bai","year":"2020","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jmgm.2025.109049_bib9","doi-asserted-by":"crossref","first-page":"35853","DOI":"10.1039\/D3RA07562A","article-title":"Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies","volume":"13","author":"Elgammal","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2025.109049_bib10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmgm.2025.109049_bib11","article-title":"Molecular bases of VEGFR-2-mediated physiological function and pathological role","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jmgm.2025.109049_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1758834011428147","article-title":"Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential","volume":"4","author":"Delbaldo","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jmgm.2025.109049_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/tcrm.2007.3.2.341","article-title":"Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)","volume":"3","author":"Le Tourneau","year":"2007","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.jmgm.2025.109049_bib14","series-title":"Medicinal Chemistry of Anticancer Drugs","first-page":"493","article-title":"Anticancer drugs acting on signaling pathways, part 1: tyrosine kinase inhibitors","author":"Avenda\u00f1o","year":"2023"},{"key":"10.1016\/j.jmgm.2025.109049_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ejoc.201403088","article-title":"Synthesis and cytotoxic activity of self\u2010assembling squalene conjugates of 3\u2010[(Pyrrol\u20102\u2010yl)methylidene]\u20102,3\u2010dihydro\u20101 H \u2010indol\u20102\u2010one anticancer agents","volume":"2015","author":"Buchy","year":"2015","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.jmgm.2025.109049_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jmgm.2025.109049_bib17","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/molecules24213839","article-title":"Heterocycles in medicinal chemistry","volume":"24","author":"Jampilek","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109049_bib18","series-title":"Key Heterocycle Cores for Designing Multitargeting Molecules","first-page":"211","article-title":"Oxindole","author":"Kaur","year":"2018"},{"key":"10.1016\/j.jmgm.2025.109049_bib19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/molecules25092031","article-title":"Synthesis, biological evaluation and in silico studies of certain oxindole\u2013indole conjugates as anticancer CDK inhibitors","volume":"25","author":"Al-Warhi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109049_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126845","article-title":"Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity","volume":"30","author":"Christodoulou","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2025.109049_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5958\/2394-2797.2016.00022.8","article-title":"Synthesis, characterization and evaluation of some benzothiazole derivatives bearing oxindole moiety as potential anticancer agents","volume":"3","author":"Dipesh","year":"2016","journal-title":"Inter. Jour. of Pharma. Chem. and Ana."},{"key":"10.1016\/j.jmgm.2025.109049_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bmc.2016.02.047","article-title":"Design, synthesis of phenstatin\/isocombretastatin-oxindole conjugates as antimitotic agents","volume":"24","author":"Kumar","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejmech.2016.07.019","article-title":"New (E)-1-alkyl-1 H-benzo[d]imidazole-2-yl)methylene)indolin-2-ones: synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies","volume":"122","author":"Sharma","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132903","article-title":"3-Substituted-2-oxindole derivatives: design, synthesis and their anti-tuberculosis and radical scavenging dual-action studies","volume":"1261","author":"Hublikar","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109049_bib25","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.arabjc.2015.02.025","article-title":"Design, synthesis and biological evaluation of 5-(2-(4-(substituted benzo[d]isoxazol-3-yl)piperazin-1-yl)acetyl)indolin-2-one and 5-(2-(4-substitutedpiperazin-1-yl)acetyl)indolin-2-one analogues as novel anti-tubercular agents","volume":"12","author":"Naidu","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bmcl.2018.02.023","article-title":"Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent","volume":"28","author":"Yousuf","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2025.109049_bib27","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/slct.201904320","article-title":"Synthesis of 1,2,3\u2010triazole tethered 3\u2010Hydroxy\u20102\u2010oxindoles: promising corrosion inhibitors for steel in acidic medium and their anti\u2010microbial evaluation","volume":"5","author":"Sampath","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2025.109049_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103619","article-title":"Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors","volume":"96","author":"Salem","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib29","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.3390\/molecules27154921","article-title":"Identification of 3-oxindole derivatives as small molecule HIV-1 inhibitors targeting tat-mediated viral transcription","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109049_bib30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/molecules24061037","article-title":"Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19","volume":"24","author":"Conti","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109049_bib31","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s11030-021-10372-7","article-title":"Anticonvulsant activity, molecular modeling and synthesis of spirooxindole-4H-pyran derivatives using a novel reusable organocatalyst","volume":"26","author":"Emami","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2025.109049_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acschemneuro.9b00619","article-title":"Novel oxindole\u2013curcumin hybrid compound for antioxidative stress and neuroprotection","volume":"11","author":"Hirata","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109049_bib33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2147\/DDDT.S65997","article-title":"Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents","author":"Liang","year":"2014","journal-title":"DDDT"},{"key":"10.1016\/j.jmgm.2025.109049_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4155\/fmc-2017-0037","article-title":"Oxindole-based syk and Jak3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation","volume":"9","author":"Kaur","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib35","first-page":"681","volume":"vol. 9","author":"Khan","year":"2013"},{"key":"10.1016\/j.jmgm.2025.109049_bib36","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.bmcl.2017.06.065","article-title":"Oxindole-based intraocular pressure reducing agents","volume":"27","author":"Zaryanova","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2025.109049_bib37","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.bmc.2018.08.022","article-title":"Design, synthesis and in vitro study of densely functionalized oxindoles as potent \u03b1-glucosidase inhibitors","volume":"26","author":"Luthra","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bioorg.2017.12.001","article-title":"Oxindole based oxadiazole hybrid analogs: novel \u03b1 -glucosidase inhibitors","volume":"76","author":"Taha","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2018.05.051","article-title":"Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors","volume":"155","author":"Guo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2017.03.089","article-title":"Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents","volume":"134","author":"Romagnoli","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107991","article-title":"Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: a structure-based virtual screening study","volume":"108","author":"Jayaraman","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110164","article-title":"Harnessing marine natural products to inhibit PAD4 triple mutant: a structure-based virtual screening approach for rheumatoid arthritis therapy","volume":"761","author":"Panchalingam","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmgm.2025.109049_bib43","doi-asserted-by":"crossref","first-page":"37250","DOI":"10.18632\/oncotarget.16763","article-title":"Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule","volume":"8","author":"Argyros","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmgm.2025.109049_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107829","article-title":"Design, synthesis, and in silico insights of novel N\u2019-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitors","volume":"153","author":"Eldehna","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib45","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/14756366.2022.2103552","article-title":"Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation","volume":"37","author":"Taghour","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib46","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.jmgm.2025.109049_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/369061","article-title":"Crystallographic and DFT studies on pyrrolo[1,2- c ]imidazole scaffolds","volume":"2014","author":"Jayaraman","year":"2014","journal-title":"Journal of Crystallography"},{"key":"10.1016\/j.jmgm.2025.109049_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2025.109049_bib49","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109049_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116204","article-title":"Virtual screening assisted discovery of novel natural products to inhibit the catalytic mechanism of Mycobacterium tuberculosis InhA","volume":"335","author":"Jayaraman","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jmgm.2025.109049_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107768","article-title":"An integrated computational investigation to unveil the structural impacts of mutation on the InhA structural gene of Mycobacterium tuberculosis","volume":"101","author":"Jayaraman","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109049_bib52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/prot.340110305","article-title":"Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations","volume":"11","author":"Ichiye","year":"1991","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2025.109049_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/prot.21344","article-title":"Free energy landscape of a biomolecule in dihedral principal component space: sampling convergence and correspondence between structures and minima","volume":"67","author":"Maisuradze","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2025.109049_bib54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa \u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109049_bib55","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1016\/j.csbj.2022.08.017","article-title":"Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease","volume":"20","author":"Naha","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jmgm.2025.109049_bib56","article-title":"Marine compound-carpatamide D as a potential inhibitor against TOP2A and its mutant D1021Y in colorectal cancer: insights from DFT, MEP and molecular dynamics simulation","author":"Priyamvada","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jmgm.2025.109049_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ph17010022","article-title":"Computer-aided drug design and drug discovery: a prospective analysis","volume":"17","author":"Niazi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109049_bib58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2025.109049_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1227643","article-title":"Unleashing Nature's potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations","volume":"10","author":"Baammi","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmgm.2025.109049_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0969-2126(99)80042-2","article-title":"Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis","volume":"7","author":"McTigue","year":"1999","journal-title":"Structure"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:41:42Z","timestamp":1762364502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"alternative-id":["S1093326325001093"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109049","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing novel potent oxindole derivatives as VEGFR2 inhibitors for cancer therapy: Computational insights from molecular docking, drug-likeness, DFT, and structural dynamics studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109049"}}